Antiarrhythmic Treatment in Atrial Fibrillation

摘要

Atrial fibrillation is one of the most common forms of cardiac disturbances, diagnosed in an estimated 2.7 million to 6.1 million people in the United States, with prevalence increasing with' age. Based on the individual's symptoms, medical treatment is available to help control the heart's rate and rhythm and reduce the risk of clots or strokes. Successful strategies to restore and maintain sinus rhythm have been shown to improve symptoms and quality of life. However, selection of antiarrhythmic drugs should be based on underlying heart disease and comorbidities, due to drug interactions, adverse reaction profile, and monitoring requirements with antiarrhythmic agents. Pharmacists can play a vital role in therapy selection and recommendations for continuation of therapy.